Physician

Christopher Lee Anderson, M.D.

According to 2025 Medicare claims, Christopher Anderson, M.D. (NPI: 1992159040) practices pain management in the Elizabethtown, KY market, with the plurality of this provider's patient population coming from Hardin, KY. This provider's primary affiliated billing organization is COMMONWEALTH PAIN ASSOCIATES, PLLC (NPI: 1306280177; TIN: 461507241) and primary practice location at 42701-7280.

Anderson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,189 traditional Medicare patients, billed 16,281 HCPCS/CPT codes, and received $484,424 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,874 prescription claims across 1,542 beneficiaries totaling $187,419 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 25 records totaling $958. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $330 to $187,419. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	1,349	4,823	$330,987
2022	1,762	15,255	$660,913
2023	1,542	18,086	$679,595
2024	1,189	16,281	$484,424

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	11	$330
2017	N/R	31	$1,528
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	685	1,701	$69,533
2022	1,375	6,493	$261,432
2023	1,568	7,859	$285,188
2024	1,542	6,874	$187,419

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	431	525	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	353	430	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	371	412	$12
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	230	2,090	$1
J1100	Injection, dexamethasone sodium phosphate, 1 mg	238	4,710	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	3,413	98,752	$58,705
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	2,067	60,405	$42,833
Xtampza Er	Oxycodone Myristate	21	608	$14,958
Oxycontin	Oxycodone Hcl	25	726	$7,279
Oxycodone Hcl	Oxycodone Hcl	319	9,319	$5,730

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$958	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Lee Anderson, M.D.?

Tedicare shows public-source Medicare data for Christopher Lee Anderson, M.D. (NPI 1992159040), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Lee Anderson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Lee Anderson, M.D.?

Christopher Lee Anderson, M.D. is linked to COMMONWEALTH PAIN ASSOCIATES, PLLC (billing NPI 1306280177) in the available physician profile data.

Does Christopher Lee Anderson, M.D. have Open Payments data?

Christopher Lee Anderson, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.